Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study.

Mult Scler J Exp Transl Clin · 2021 · PMC8573503 · PMID 34777854

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

Exploratory outcome measures The NeuroQoL-Fatigue score also showed a trend towards greater fatigue reductions in the melatonin condition (−4.7 ± 1.9) vs. placebo condition (−2.4 ± 2.2, p = 0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.